Mylan COVID-19 Updates




As a leading global pharmaceutical company, Mylan is committed to continue doing its part in support of public health needs amid the evolving COVID-19 pandemic. While the company is focused on taking steps to protect employees and ensure a sustainable supply of critically needed medications, Mylan also is turning its scientific and operational expertise towards identifying additional ways to assist in the massive prevention, diagnosis and treatment efforts needed to counter the spread of COVID-19.

Latest News

03-25-20 Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic by Voluntarily Waiving its Marketing Exclusivity in the U.S. for Lopinavir/Ritonavir to Help Ensure Wider Availability to Meet Potential COVID-19 Patient Needs

03-25-20 Mylan Statement Regarding India Manufacturing Facilities

03-19-20 Mylan Ramps Up U.S. Manufacturing of Hydroxychloroquine Sulfate Tablets to Meet Potential COVID-19 Patient Needs